IGF1-LR3 is widely used to investigate anabolic, anti-catabolic, and cell survival pathways in both in vivo and in vitro research settings 1-4
Once a vial is punctured for first use, follow the in-use BUD printed on your specific label (typically 28 days at refrigerator temperature)
Unlike full HGH, it does not raise IGF-1, does not affect blood sugar, does not stimulate growth in non-fat tissue, and does not interfere with the pituitary's own growth hormone signalling
Why it matters for body composition: Mitochondria are the powerhouses of the cell, and crucial for fat metabolism and muscle performance
Starting Dose 20 units (0.24mg AOD + 0.4mg MOTs-C + 0.4mg Tesa + 0.4mg Ipa) Form Injectable vial (5mL, 1.2mg-2mg-2mg-2mg/mL, AOD-9604 6mg + MOTs-C 10mg + Tesamorelin 10mg + Ipamorelin 10mg total) Dosing Protocol 20 units subcutaneous injection daily for 5 days, 2 days off